It has been reported that miR-1307 and miR-127-3p are downregulated in DDP-resistant breast cancer and lung cancer cell, respectively, and, mechanistically, they directly targeted MDM4 and MDM2, promoting DDP-resistance (Wang and Zhu, 2018; Zeng et al., 2020). Here, MDM4 is linked to breast carcinoma.